Red Cedar Capital’s Zimmer Biomet ZBH Stock Holding History

Red Cedar Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$38K	Hold	300	–	–	0.02%	100
2022 Q3	$31K	Hold	300	–	–	0.02%	103
2022 Q2	$32K	Hold	300	–	–	0.02%	104
2022 Q1	$38K	Sell	300 -9	-3%	-$1.08K	0.02%	100
2021 Q4	$38K	Hold	309	–	–	0.02%	100
2021 Q3	$44K	Hold	309	–	–	0.03%	92
2021 Q2	$48K	Hold	309	–	–	0.03%	90
2021 Q1	$48K	Hold	309	–	–	0.03%	91
2020 Q4	$46K	Sell	309 -438	-59%	-$61.9K	0.03%	86
2020 Q3	$99K	Hold	747	–	–	0.09%	72
2020 Q2	$86K	Hold	747	–	–	0.08%	73
2020 Q1	$73K	Hold	747	–	–	0.07%	73
2019 Q4	$109K	Hold	747	–	–	0.08%	72
2019 Q3	$100K	Hold	747	–	–	0.08%	75
2019 Q2	$85K	Hold	747	–	–	0.07%	79
2019 Q1	$93K	Hold	747	–	–	0.08%	77
2018 Q4	$75K	Hold	747	–	–	0.07%	78
2018 Q3	$95K	Hold	747	–	–	0.08%	77
2018 Q2	$81K	Hold	747	–	–	0.07%	82
2018 Q1	$79K	Hold	747	–	–	0.07%	83
2017 Q4	$87K	Buy	+747	New	+$84.5K	0.07%	77

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Red Cedar Capital's ZBH Position: Q4 2022 in Review

Red Cedar Capital held its Zimmer Biomet (ZBH) position steady in Q4 2022 at 300 shares worth $38K. The position accounts for 0.02% of the portfolio, ranked #100.

Red Cedar Capital first reported a position in ZBH in Q4 2017 and has held it in 21 quarters since. The position peaked at $109K in Q4 2019. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

Red Cedar Capital held 300 shares of Zimmer Biomet worth $38K as of Q4 2022.
Red Cedar Capital left its Zimmer Biomet share count unchanged in Q4 2022.
Zimmer Biomet made up 0.02% of Red Cedar Capital's portfolio in Q4 2022, its #100 holding.
Red Cedar Capital first reported a position in Zimmer Biomet in Q4 2017 and has held it in 21 quarters since.
Red Cedar Capital's Zimmer Biomet position peaked at $109K in Q4 2019.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Red Cedar Capital's 13F filing for Q4 2022, filed 6 Feb 2023.